Glancy Prongay Wolke & Rotter Secures Class Certification for Verrica Investors
Tue 17th Mar 2026 | Posted by Melissa Wright, on News
On March 4, 2026, the Honorable Kai N. Scott of the U.S. District Court for the Eastern District of Pennsylvania certified a class of investors in a securities fraud case against Verrica Pharmaceuticals, Inc. and its former top executives. In granting the plaintiffs’ motion and appointing Glancy Prongay Wolke & Rotter to serve as class counsel, the Court commended the attorneys’ skill and experience, stating:
“It is a lamentable rarity for the Court to decide a motion where the quality of briefing and the quality of oral argument are both top notch. It is, however, the Court’s good fortune to have encountered both excellent briefing and excellent oral argument in this matter.”
The case alleges that Verrica, a dermatology therapeutics company, misled investors regarding the pathway to FDA approval for its leading drug candidate, causing the company’s stock price to be artificially inflated. The certified class includes all purchasers of the publicly traded common stock of Verrica between May 19, 2021, and May 24, 2022, both dates inclusive.
Glancy Prongay Wolke & Rotter defeated Verrica’s motion to dismiss the case in 2024.
GPWR attorneys Leanne Heine Solish, Rebecca Dawson, Lee Albert, and Greg Linkh are leading the litigation strategy for plaintiffs and obtained this result for the class.
The class action is ongoing.